Structure-based exploration and pharmacological evaluation of N-substituted piperidin-4-yl-methanamine CXCR4 chemokine receptor antagonists
-
Add time:07/17/2019 Source:sciencedirect.com
Using the available structural information of the chemokine receptor CXCR4, we present hit finding and hit exploration studies that make use of virtual fragment screening, design, synthesis and structure-activity relationship (SAR) studies. Fragment 2 was identified as virtual screening hit and used as a starting point for the exploration of 31 N-substituted piperidin-4-yl-methanamine derivatives to investigate and improve the interactions with the CXCR4 binding site. Additionally, subtle structural ligand changes lead to distinct interactions with CXCR4 resulting in a full to partial displacement of CXCL12 binding and competitive and/or non-competitive antagonism. Three-dimensional quantitative structure-activity relationship (3D-QSAR) and binding model studies were used to identify important hydrophobic interactions that determine binding affinity and indicate key ligand-receptor interactions.
We also recommend Trading Suppliers and Manufacturers of naphthalen-2-yl(phenyl)methanamine (cas 16149-05-6). Pls Click Website Link as below: cas 16149-05-6 suppliers
Prev:Vibrational properties of diterpene rel-(1S, 4aS, 7S,8aS)-7-(vinyl)-tetradecahydro-1,4a-dimethylphenanthrene-7,8a-carbolactone-1-carboxylic acid studied by Raman and infrared spectroscopy together with ab initio calculations
Next:Cyclopalladation of (E)-N-(2,6-dichlorobenzylidene)(naphthalen-1-yl)methanamine: Synthesis and X-ray molecular structure of [κ2-N,C1-η2-C3,C4-Pd{(PhCCPh)2–C10H6–CH2–NCH–(2,6-Cl2C6H3)}Cl]·CH2Cl2) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Novel methodology for the synthesis of the benzo[b]phenanthridine and 6H-dibenzo[c,h]chromen-6-one skeletons. Reactions of 2-naphthylbenzylamines and 2-naphthylbenzyl alcohols07/19/2019
- Cyclopalladation of (E)-N-(2,6-dichlorobenzylidene)(naphthalen-1-yl)methanamine: Synthesis and X-ray molecular structure of [κ2-N,C1-η2-C3,C4-Pd{(PhCCPh)2–C10H6–CH2–NCH–(2,6-Cl2C6H3)}Cl]·CH2Cl207/18/2019


